Biotech

All Articles

Life scientific research credit score organization unveils with $600M

.A brand-new international lifestyle scientific research credit scores company, referred to Symbioti...

BMS channels TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional big wager from the Caforio era, ending an offe...

Nuvation halts wager prevention after taking into consideration stage 1 record

.After looking at phase 1 data, Nuvation Bio has actually made a decision to halt work with its one-...

' Medical instinct' led FDA experts to back Zevra's rare health condition med

.Zevra Therapies' rare disease medicine appears to become on the road to approval this fall after ob...

Pfizer takes $230M struck after axing stopped working DMD gene therapy

.Pfizer's phase 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has blown a $230 mi...

AC Immune views 'site' prospective in Alzheimer's medicine data

.After greater than two decades of deal with neurodegenerative diseases, Swiss biotech AC Immune cla...

GSK falls ph. 2 HPV injection over shortage of best-in-class potential

.GSK has actually broken up a stage 2 individual papillomavirus (HPV) injection coming from its own ...

OS Therapies refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.OS Therapies are going to specify on the NYSE American sell swap this morning by means of a $6.4 th...

ALX's waning CD47 response price delivers stock spiraling down

.ALX Oncology's stage 2 gastric cancer cells reaction fee has compromised. After viewing its own CD4...

Ionis centers eye disease coming from aim ats of Roche-partnered possibility after records disappoint

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has disappointed assumptions, mot...